Inflation is perhaps one of the most known words in economics simply because of the widespread ramifications that it can have at a macro as well as at a household level. Simply put, inflation measures the general increase in the price of goods and services, over a specific period.

At a macro level, it has significant bearing on the monetary policy and interest rates which in turn influence capital investment and productive capacity in an economy. Case in point being the current chatter around reversing the prevailing low interest rate regime and raising interest rates.

While a rise in rates can potentially mitigate the impact of rising inflation, central banks also cannot put at risk the tepid recovery that is currently underway. At a household level, inflation directly has an impact on the purchasing power of your money and can influence your saving, investment, and spending journeys.

Inflation and Its Relationship With Your Investment Portfolio

Intuitively you would understand that if inflation alludes to a general increase in prices, fixed income bearing securities might not be an optimal investment option since the returns will not be able to make up for the rise in general prices. Further, the price of fixed income securities is inversely related with interest rates. When interest rates rise, prices fall and vice-versa.

One of the tools used by central banks to combat inflation is interest rates. Thus, in an inflationary environment, interest rates are likely to eventually rise, thereby negatively impacting fixed-income securities.

The impact of inflation on equity investments is less definite. Transient inflation may have little to no effect on equity prices and might even have a positive impact on companies that sell products with inelastic demand. However, persistently high inflation will have a two-fold impact on companies.

On the one side it will impact consumer sentiment and deflate demand and on the other side it will increase the cost of capital due to rising interest rates, thereby dampening equity prices. All physical, real assets would potentially gain from inflation since their prices define the underlying inflation.

At a macro level of global and domestic markets, inflation is one of the risk factors which impacts economic cycles and can disrupt countries if not economies in addition to wealth. Thus,

  • In tough times when demand is low, governments tend to reduce interest rates / pump in liquidity boosting measures and production, causing all round growth and asset price increases.
  • This in turn kicks in inflation, causing too much money to chase too few goods, forcing economic control by increasing interest rates.
  • If not managed properly it can lead to either hyper-inflation or an economic recession which can disrupt a country or even the world.

Where Should You Invest To Combat High Inflation

Here are some of the investment avenues to consider making your investment portfolio inflation proof:

  • Equities

Equity investments are considered as an optimal way to hedge your portfolio against inflation. Long-term index returns for Nifty and Sensex are in the 12%  to 15% compound annual growth rate (CAGR) range, which is considerably higher than India’s long-term average CPI inflation of approximately 5% to 6%. This translates to 6% to 9% real returns on investments in the long term.

Within equities, investment in value stocks could be ideal as these companies generally have better pricing power or inelastic demand which enables them to align the prices of their goods and services with inflation in a better way than companies in other sectors.

  • Real estate 

The sector has traditionally proved to be a good hedge against inflation as property prices tend to witness price increases over the long-term. Real estate investment trusts or REITs are an easy way for you to gain access to real estate investments without having to shell out a fortune to buy them.

Also, REITs often pay interest and dividends as regular distributions. With dividends not being taxed (REITs in India), the overall net of tax payout to the investor tends to be superior from such investments.

  • High yield bonds with short – medium duration

This is a good option to ensure that your investments earn a positive real return (adjusted for inflation).

In India, high yields generally range between 8% to 10% in the mutual fund space while options in venture debt or venture debt funds or real estate debt funds, etc., can offer yields upwards of 12% and can go as high as 19% to 20%.

  • International investments

An increase in inflation not only erodes the absolute value of a currency, but also its value vis-à-vis other currencies. International investments, especially in U.S. or euro-denominated assets can help you diversify your investment portfolio and also provide a hedge against currency depreciation.

A 20% to 25% allocation to such assets which are outside of INR assets offer a good counter-inflation strategy in the portfolio in the long run (this might not necessarily play out in the shorter-term where there is inflation across global economies).

  • Commodities

Historically, gold has proved to be an excellent hedge against inflation due to which most portfolios are advised to allocate 5% to 10% to gold investments. However, more recently, gold has been witnessing a higher degree of volatility and as such may no longer prove to be such a great hedge.

However, you can consider making a small allocation towards gold either through exchange traded funds (ETFs) or sovereign gold bonds (annual coupon + capital gains).

Bottom Line

To hedge your investments against inflation, the critical aspect is to look for investment opportunities that are undervalued through value stocks or markets that are relatively reasonable in their valuations apart from real assets like gold which have acted as traditional hedge.

The key, however, hinges on how economic policies navigate the interest rate and the demand maze that helps strike the right balance between controlling inflation yet protecting economic growth.

Information provided on Forbes Advisor is for educational purposes only. Your financial situation is unique and the products and services we review may not be right for your circumstances. We do not offer financial advice, advisory or brokerage services, nor do we recommend or advise individuals or to buy or sell particular stocks or securities. Performance information may have changed since the time of publication. Past performance is not indicative of future results.

Forbes Advisor adheres to strict editorial integrity standards. To the best of our knowledge, all content is accurate as of the date posted, though offers contained herein may no longer be available. The opinions expressed are the author’s alone and have not been provided, approved, or otherwise endorsed by our partners.

Leave a comment

Vijay Gomatam

Consultant – Investment Banking

Vijay Gomatam has over 20 years of banking experience across M&A, corporate finance, capital markets, and corporate banking, with a strong focus on cross-border deal origination and execution across India, Southeast Asia, Japan, and Australia. He has deep sector expertise in industrials, IT services, media, and telecom, with extensive experience in India - Southeast Asia and India–Japan transactions. Vijay previously served as Director at MUFG Bank, Singapore, where he led the India - Japan M&A corridor, and earlier worked with Deutsche Bank, Merrill Lynch, Houlihan Lokey, and Edelweiss Alternative Asset Advisors.

His transaction experience includes Motherson Group’s acquisition of TSE-listed Yachiyo Industries, Takahata India’s stake sale to SPRL, Toppan Form’s acquisition of PT RDS in Indonesia, Mitsui’s investment in FKS Food & Agri, CVC’s investment in PT LinkNet, and capital market transactions for Southeast Asian media and telecom clients including SingTel, Axiata, and Bakrie Group.

He holds an MBA from IIM Calcutta and a B.E. (Hons.) from Nanyang Technological University, Singapore.

Akbar Khan

Senior Advisor – Investment Banking

Akbar Khan has over twenty years of experience across M&A advisory, Private Equity, and Corporate M&A, along with a decade as an entrepreneur and operator. He has held senior roles at Bank of America Merrill Lynch in India and London, where he led Telecom & Technology Investment Banking, Private Equity coverage, and M&A, and at General Electric, where he served as Head of Corporate Development and M&A for India and the MENA region. He has advised global corporates and financial sponsors including Reuters Plc, Telecom Italia, Hellenic Telecom, MTN, Tata Group, Apax Partners, Warburg Pincus, and TA Associates, and has led several notable transactions. These include advising E2E Networks on

its USD 50M capital raise, QuEST Global on its USD 75M Series B private placement to Warburg Pincus, Rain Technologies on its USD 65M Series A financing from QED Investors and Invus, Augnito.ai on its Pre-Series A raise from Apollo Hospitals Group, Tata Consultancy Services on the acquisition of Citigroup’s captive back-office unit, Forthnet in Greece on the acquisition of Netmed, and Telecom Italia on the sale of Cosmote via a leveraged buyout by Apax Partners and TPG.

In addition, Akbar co-founded and served as CEO of Rain Technologies India an earned wage access fintech platform.

He holds an MBA from London Business School and is a UK-qualified Chartered Accountant.

Shreyan ML

Managing Director – Healthcare & Pharma

Shreyan ML leads the healthcare and pharma investment banking practice and brings over 15 years of experience across investment banking, corporate M&A, and management consulting within the pharmaceutical sector. Prior to joining MAPE, he worked with Spark Capital, Strides Group, Wanbury Limited, and Tata Strategic Management Group.

His deal experience includes advising Curatio Healthcare on the sale of its business to Torrent Pharmaceuticals; Sale of TTK’s human pharma business to Bharat Serums; Glenmark Pharmaceuticals on the sale of the Razel brand to KKR-backed JB Chemicals & Pharma and the sale of nine dermatology brands to Eris Oaknet.

As Corporate M&A Head at Strides Group, he was involved in thesale of Agila to Mylan and led the animal health strategy at Sequent Scientific, executing over 12 transactions including fundraises and cross-border acquisitions.

He holds an MBA from IIM Indore and is a computer engineer from NIT Karnataka.

Arjun Mukherjee

Managing Director – Investment Banking

Arjun Mukherjee brings over 20 years of investment banking experience, with a strong focus on mergers & acquisitions and capital raising across Industrials, Education, Telecom, Cement, and Healthcare sectors. Prior to joining InCred Capital, he was part of the senior leadership team at MAPE Advisory Group for over a decade and has previously worked with Lazard, Ambit Capital, and Macquarie Capital.

His deal experience includes advising Veranda Learning on multiple acquisitions and its IPO, Emami on its bid for Paras Pharma, HeidelbergCement on the acquisitions of Mysore Cement and Indo Rama Cement, Italcementi on the acquisition of Sri Vishnu Cement along with an open offer, Bharti Airtel on the acquisitions of Hexacom India and the Spice Calcutta circle, as well as the sale of NLD rights to VSNL, Advent on its bid for Lafarge India.

He has also advised Jagdale Industries on the sale of its electrolyte drinks brand to Johnson & Johnson, promoters of Orissa Sponge on stake sales to Bhushan Steel and Monnet Ispat and on takeover defence, Fortis Healthcare on takeover defence and the sale of a minority stake to Khazanah, ICI India on the sale of its Nitrocellulose business to Actis and its rubber chemicals business, Jai Balaji Industries on the sale of its DI pipe unit and on QIP fund raising, Orbit Corporation and Ansal APIL on QIP-led equity fund raises, Walton Street Capital on raising a USD 500 million India-focused real estate fund, and on acquisition debt funding for the purchase of the RL Fine Chem API business.

Ashish Ambwani

Managing Director – Investment Banking

Ashish Ambwani has two decades of investment banking experience with a focus on cross-border M&A and Private Equity, and deep sector expertise across Consumption &Retail, Industrials and Digital businesses. He previously served as Director at Lazard for over 12 years and began his career at KPMG.

He has worked on numerous transactions including Osam Dairy’s sale to Dodla Dairy, Livpure’s capital raise from M&G Investments, QIMA’s acquisition of EFRAC Limited, Raymond Consumer Care’s FMCG sale to Godrej Consumer, IPO of Ethos Limited, Manohar Packaging’s sale to Parksons Packaging, MM Polytech’s sale to Huhtamaki, YY Inc.’s acquisition of Bigo, Kama Ayurveda’s fund raise and sale to Puig, Magnet360’s sale to Mindtree, Danone’s acquisition of Wockhardt nutrition assets, UCB’s sale of Indian brands to Dr Reddy’s, Sabero Organics’ sale to Coromandel, International Paper on its acquisition of AP Paper, Avantor on its acquisition of RFCL.

He holds an MBA from IIM Lucknow and a has a degree in Electrical & Electronics Engineering from NIT Trichy.

Jacob Mathew

Consultant- Investment Banking

Jacob Mathew brings over 25 years of experience in investment banking, private equity, and fundraising. He co-founded MAPE Advisory, a boutique investment bank focused on mid-market companies. Prior to MAPE, he was a Vice President (M&A) at Merrill Lynch India and played a key role in setting up the corporate finance practice at PwC India.

He has worked and led numerous transactions including the acquisition of Coats Viyella’s garment business by the AV Birla Group, the sale of Burnol and Coldarin brands, Dr Reddy’s buyout of American Remedies, and the sale of Diamond Dychem to Ciba AG. At MAPE, he led transactions across technology, telecommunications, consumer, healthcare, and retail sectors. His key clients include Coffee Day Enterprises, Strides, Igarashi Motors, J&J India, and Jyothi Labs.

He holds a PGDM from IIM Calcutta and is a Civil Engineer.

M Ramprasad

Consultant – Investment Banking

M Ramprasad has over 25 years of experience across investment banking, private equity, and fundraising. He co-founded MAPE Advisory, a boutique Indian investment bank focused on mid-market companies, which later merged with the Investment banking team at InCred in 2020. Prior to MAPE, he was a Senior Vice President at Merrill Lynch India, leading South India operations.

He has led marquee transactions for leading business groups including Tata Group, DuPont, ICICI Bank, Dr Reddy’s, and Sify, and at MAPE advised on landmark deals across manufacturing, infrastructure, and financial services. His key clients include Murugappa Group, ELGi Equipments, Curatio, Jyothi Labs, Karvy Financial Group, Star Health, and CRH Group.

He holds a PGDM from BIM Trichy and a degree in Chemistry.

Sanjay Singh

Head of Investment Banking – InCred Capital

Sanjay Singh is the Head of Investment Banking at InCred Capital, where he leads coverage across both advisory and equity capital markets. He brings over 20 years of experience across investment banking, strategy, and operations, with deep expertise in the pharmaceuticals and healthcare sectors.

Prior to joining InCred, he held leadership roles at BDA Partners as Head of India and Co-Head of Healthcare Asia, and at KPMG as Partner and Head of Life Sciences in India. He has also worked with Dr. Reddy’s Laboratories and Glenmark Pharmaceuticals.

His transaction experience includes advising Chemfield Cellulose on its divestment to Oji Holdings, Archimica S.p.A. on its acquisition by PI Industries, Synokem Pharmaceuticals on growth investment from TA Associates, Isagro SpA on the divestment of Isagro Asia Agrochemicals to PI Industries, SMT on its equity raise from Morgan Stanley Private Equity, Astec LifeSciences on the sale of equity to Godrej Agrovet and Nihon Nohyaku on its acquisition of Hyderabad Chemical Limited amongst others.

Sanjay holds an MBA from IIM Bangalore and a B Tech from IIT BHU.